| Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are revolutionizing the management of type 2 diabetes and obesity. Exciting new research suggests these medications may also hold immense promise for treating... |
Context: Teso region in Eastern Uganda has one of the highest levels of alcohol and drug use Nationally. A project intervention aimed at preventing harmful use of alcohol and drugs among youth was initiated with support of Movendi /IOGT-NTO...
Background
Stigma related to drug use is a well-documented barrier to engaging and remaining on medication for opioid use disorder (MOUD), yet little is known about how stigma operates across multiple social and institutional settings in...
Background
Smoking is more common in lower socioeconomic position (SEP) groups, but smoking cessation interventions are less effective for these groups. StopCoach, an mHealth intervention, supports people with lower SEP in quitting smoking...
Background
The opioid epidemic continues to pose significant challenges in the United States, with over 75% of nearly 107,000 drug overdose deaths in 2022 involving opioids. Recently, efforts to curb the epidemic have made strides...
Background and Objectives: Cognitive behavioral therapy (CBT) is the first-line treatment for gaming disorder (GD), as it addresses background factors. However, certain limitations exist. Cognitive training has been explored as an...
Drug abuse is increasingly concerning, requiring a rehabilitative approach through effective counselling by the Indonesian Government by strengthening drug prevention and eradication, because drug abuse in Indonesia is increasingly...
Substance abuse in Indonesia is on the rise each year. Rehabilitation centers play a crucial role in helping individuals recover from addiction and improve their quality of life (recovery, productivity, and social functioning). However...
Adolescent drug abuse in Indonesia is rising, with prevalence among ages 15-24 increasing from .96% IN 2021 to 1.97% in 2023. About 181 per 10,000 adolescents as of February 2025. BNN recorded 3.3 million drug users, including 312,000...
The research is motivated by the results of a preliminary study at the Rehabilitation Center of National Narcotics Board Lido which shows the existence of drug abuse with a wide range of age groups at the age of 12-60 years and various...
Co-occurring disorder is a condition where substance use disorder accompanied by other mental health problem that occur simultaneously and mutually influence disease symptom, health outcomes and risk of relapse. Around 35% people age 18 and...
INTRODUCTION: The addiction workforce encompasses a diverse group of professionals across various sectors, such as prevention, harm reduction, treatment, and recovery. Training for this workforce is highly variable both at local and...
ISSUP, in partnership with the International Consortium of Universities for Drug Demand Reduction (ICUDDR), recently hosted an engaging and forward-looking webinar titled “Reimagining Prevention: The Role of Generative Artificial...
This groundbreaking book breaks down the latest research to reveal how trauma impacts our bodies on a cellular level and offers an empowering path to whole-body healing.
Today, we know more about mental health than ever before, but...
On June 26, 2025, the International Consortium of Universities for Drug Demand Reduction (ICUDDR) marked an important milestone with the global launch of the Universal Nurses Addiction Curriculum (UNAC). This initiative, supported by the U...
The International Standards for the Treatment of Drug Use Disorders, developed by UNODC and WHO, provide guidance for countries to strengthen evidence-based, ethical and effective treatment systems. They are designed for policymakers...
As a follow-up to our previous webinar outlining the Key Findings of the World Drug Report 2025, ISSUP on 28 August 2025 presented a review of the World Drug Report 2025 through an African lens. The webinar was moderated by Radolf Nortey...
